Background
Cancer in the mouth and back of the throat is notoriously difficult to detect. The suspicious tissues, or oral lesions, often resemble mouth sores or patches from other common or harmless conditions, posing a challenge for clinicians to identify. The gold standard for screening is to biopsy the lesions, a technique that has low specificity and sensitivity and that can cause pain and dysfunction in patients. These limitations can delay detection and diagnosis.